Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI) -- Ignore unavailable to you. Want to Upgrade?

To: W Shakespeare who wrote (407)	2/16/2001 11:26:19 AM
From: Robert G. Harrell	Read Replies (1) \| Respond to of 413

Hi Will, I found this little nugget this morning from Bank of America Securities: <<snip>> VISX, INCORPORATED (EYE) MARKET PERFORMER Price: $16.03 Target Price: Strong 1Q01 U.S. Procedure Volumes Prompts Increase In Estimates ? Based on anecdotal information from a number of different industry sources, 1Q01 U.S. refractive procedure volumes appear to be pacing at a much stronger rate than we had previously estimated. ? We are raising our Visx 1Q01 EPS estimate to $0.19 from $0.17 and our 2001 estimate to $0.79 from $0.74 to reflect a higher level of procedure volumes, we are raising our forecast for 1Q01 Visx sequential procedure volume growth to 10% from 5%. <<snip>> investor.cnet.com I'm still holding about 4k shares bought at 5 1/4 down from over 10k bought at much higher prices. This and Visx have been great lessons in listening to the market rather than to the analysts. I lost a bunch on them. Good luck, Bob